(Q33377610)

English

Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Comparison of single bolus ATG and Basiliximab as induction therapy in presensitized renal allograft recipients receiving tacrolimus-based immunosuppressive regimen (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

author name string

Shun-liang Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dong Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wei-zhen Wu

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Wen-hong Lin

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Ting-zhao Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jin-quan Cai

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Jian-ming Tan

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

publication date

28 August 2007

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Transplant Immunology

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

281-285

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Predicting kidney graft failure by HLA antibodies: a prospective trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Intravenous gammaglobulin (IVIG): a novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Short and long-term results after pretransplant high-dose single ATG-fresenius bolus in cadaveric kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Intraoperative anti-thymocyte globulin-Fresenius (ATG-F) administration as induction immunosuppressive therapy in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

One year results of preoperative single bolus ATG-Fresenius induction therapy in sensitized renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

National conference to assess antibody-mediated rejection in solid organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Induction versus noninduction therapy in kidney transplantation: considering different PRA levels and different induction therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

The role of anti-IL-2 receptor in high-risk kidney transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Comparison of daclizumab, an interleukin 2 receptor antibody, to anti-thymocyte globulin-Fresenius induction therapy in kidney transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Induction therapy with basiliximab versus Thymoglobulin in African-American kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Long-term toxicity of antithymocyte globulin induction may vary with choice of agent: a single-center retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Lymphomas after solid organ transplantation: a collaborative transplant study report

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Intraoperative T-cell depletion prior to completion of anastomoses by high-dose single ATG bolus as a new approach to improve long-term results after kidney transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Preoperative ATG bolus treatment increase CsA sensitivity of peripheral blood lymphocytes (PBLS) in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Bolus anti-thymocyte globulin induction in renal transplant recipients: a comparison with conventional ATG or anti-interleukin-2 receptor antibody induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients1

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2007.08.002

7 January 2021

Identifiers

10.1016/J.TRIM.2007.08.002

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33377610&oldid=1536539344"